Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $594.0M | $522.3M | $487.7M | $356.9M | $181.1M | $83.3M |
| Gross profit | $153.5M | $142.5M | $131.3M | $101.0M | $64.0M | $30.8M |
| Gross margin | 25.85% | 27.28% | 26.93% | 28.29% | 35.33% | 37.00% |
| Operating expenses | $168.0M | $137.5M | $172.7M | $173.3M | $82.7M | $30.7M |
| Operating income | −$14.4M | $5.0M | −$41.4M | −$72.3M | −$18.7M | $91,000 |
| Operating margin | −2.43% | 0.96% | −8.49% | −20.26% | −10.31% | 0.11% |
| EBITDA | $9.9M | $30.4M | −$8.7M | −$42.1M | $4.9M | $6.9M |
| EBITDA margin | 1.66% | 5.82% | −1.78% | −11.81% | 2.70% | 8.27% |
| Net income | −$51.4M | −$3.8M | −$41.0M | −$70.8M | −$35.0M | −$6.4M |
| Net profit margin | −8.65% | −0.73% | −8.40% | −19.85% | −19.34% | −7.63% |
| Basic EPSper basic share | -CA$0.62 | -CA$0.05 | -CA$0.53 | -CA$1.14 | -CA$0.84 | -CA$0.46 |
| Diluted EPSper diluted share | -CA$0.62 | -CA$0.05 | -CA$0.53 | -CA$1.14 | -CA$0.84 | -CA$0.46 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
Tidal Investments LLC | 1.66M |
AdvisorShares Investments LLC | 1.18M |
RENAISSANCE TECHNOLOGIES LLC | 899.93K |
TWO SIGMA INVESTMENTS, LP | 654.93K |
Federation des caisses Desjardins du Quebec | 260.11K |
Baader Bank Aktiengesellschaft | 250K |
MILLENNIUM MANAGEMENT LLC | 249.47K |
Ewing Morris & Co. Investment Partners Ltd. | 240K |
Point72 Asset Management, L.P. | 196.96K |
JANE STREET GROUP, LLC | 109.71K |
JW Asset Management, LLC | 96.64K |
Qube Research & Technologies Ltd | 86.39K |
HRT FINANCIAL LP | 80.4K |
BANK OF AMERICA CORP /DE/ | 73.1K |
MORGAN STANLEY | 71.26K |
BANK OF MONTREAL /CAN/ | 66.44K |
OLD MISSION CAPITAL LLC | 66.04K |
Walleye Capital LLC | 64.57K |
SBI Securities Co., Ltd. | 40.35K |
AXQ CAPITAL, LP | 37.83K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
High Tide ($HITI) reported fiscal third-quarter revenue of C$198.8 million, up 33%, and adjusted EBITDA of C$16.2 million, up 53%. Operating income increased to C$8.7 million. The German medical-cannabis business contributed C$38.2 million ...